Abstract
Nitric oxide (NO) modifies the functions of a variety of proteins containing cysteine thiols or transition-metal centers, particularly by S-nitrosylation. In inflamed liver, NO is overproduced and hepatic drug-metabolizing enzymes, the flavin-containing monooxygenases (FMOs) and cytochrome P450s (CYPs), are suppressed. However, the NO-related mechanisms underlying the loss of these activities are not well understood, particularly for FMOs. In this study, we suggest that FMO3, the major FMO in human liver, is modified post-translationally by NO. This hypothesis is based on the imbalance observed between the decrease in FMO3 expression (40.7% of controls) and FMO3-specific ranitidine N-oxidation activity (15.1%), and on the partial or complete reversibility of FMO inhibition by sulfhydryl-reducing regents such as DTT (effective on both S-S and S-NO adducts) and ascorbate (effective on S-NO only). Furthermore, NO donors (SNP, SNAP, and Sin-1), including the pure NO donor DEA/NO, directly suppressed in vitro FMO activity (N- or S-oxidation of ranitidine, trimethylamine, and thiobenzamide) in human liver microsomal proteins and recombinant human FMO3. These activities were restored completely after treatment with DTT or ascorbate. T...Continue Reading
References
Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J S StamlerJ Loscalzo
Feb 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M StefekV Zelník
Jan 1, 1988·Drug Metabolism Reviews·D M Ziegler
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·O G KhatsenkoJ R Vane
Oct 1, 1993·The Journal of Surgical Research·D A GellerT R Billiar
Apr 28, 1995·Chemico-biological Interactions·J R CashmanL E Cashman
Mar 1, 1995·Chemical Research in Toxicology·J R Cashman
Aug 1, 1994·Toxicology and Applied Pharmacology·W G Chung, D R Buhler
Jan 1, 1993·Archives of Biochemistry and Biophysics·D A WinkR W Nims
May 28, 1993·Biochimica Et Biophysica Acta·K ItohT Kamataki
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·D I SimonJ S Stamler
Apr 1, 1996·Toxicology and Applied Pharmacology·M MonshouwerA S Van Miert
Feb 15, 1997·The Biochemical Journal·C QuijanoR Radi
Oct 6, 1997·Biochemical Pharmacology·M B Sewer, E T Morgan
Dec 6, 1997·Biochemical and Biophysical Research Communications·J LiY M Kim
Jan 9, 1998·Drug Metabolism Reviews·E T Morgan
Apr 29, 1998·The Journal of Clinical Investigation·P L MajanoR Moreno-Otero
Aug 4, 1998·Molecular Pharmacology·M B SewerE T Morgan
Mar 27, 1999·The Journal of Biological Chemistry·S MohrB Brüne
Jul 28, 1999·Scandinavian Journal of Gastroenterology·S MitchellR Smith
Aug 27, 1999·Biochemical and Biophysical Research Communications·P M BauerL J Ignarro
Aug 27, 1999·Molecular Pharmacology·C S ParkY N Cha
Mar 30, 2000·Pharmacogenetics·J H KangY N Cha
Apr 26, 2000·The Journal of Biological Chemistry·M XianP G Wang
May 8, 2000·Journal of Applied Toxicology : JAT·P Muriel
Dec 7, 2000·Immunology·T Akaike, H Maeda
Dec 29, 2000·Japanese Journal of Pharmacology·W G ChungY N Cha
Jul 27, 2001·Current Drug Metabolism·P Y Cheng, E T Morgan
Sep 27, 2001·Cell·J S StamlerF C Fang
Dec 26, 2001·Molecular Pharmacology·Hirokazu Hara, Tetsuo Adachi
May 9, 2002·Biochemical Pharmacology·Yanbin JiBrian M Bennett
Citations
Apr 10, 2013·Biochemical Pharmacology·Hiroshi Yamazaki, Makiko Shimizu
Apr 26, 2013·The New England Journal of Medicine·Joseph Loscalzo
Aug 27, 2009·The Journal of Biological Chemistry·Pithi ChanvorachoteYon Rojanasakul
Dec 18, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jun ZhangEdward T Morgan
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·John R Cashman, Jun Zhang
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Alison E AitkenEdward T Morgan
Nov 27, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Christopher M SchonhoffM Sawkat Anwer
Nov 3, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Makiko Shimizu
Jun 15, 2007·Pharmacogenomics·Irfan M Hisamuddin, Vincent W Yang
Jan 22, 2013·Drug Metabolism Reviews·Sabine Gerbal-ChaloinMartine Daujat-Chavanieu
Aug 5, 2008·Neuroscience·H-M YuG-Y Zhang
Aug 18, 2006·The Journal of Pathology·M WoenckhausW Dietmaier
Sep 14, 2013·British Journal of Clinical Pharmacology·Makiko ShimizuIan R Phillips
Oct 7, 2004·Biochemical and Biophysical Research Communications·Seung-Duk RyuChang-Shin Park
Jul 16, 2005·Biochemical and Biophysical Research Communications·Jennifer L MarcumRodney P Guttmann
Oct 23, 2014·European Journal of Human Genetics : EJHG·Elizabeth A ShephardIan R Phillips
Mar 12, 2015·Drug Metabolism and Pharmacokinetics·Makiko ShimizuHiroshi Yamazaki
Jul 3, 2009·Drug Metabolism and Pharmacokinetics·Satomi NagashimaHiroshi Yamazaki
Jan 15, 2013·Cell Metabolism·Brian J BennettAldons J Lusis
Sep 30, 2016·Expert Opinion on Drug Metabolism & Toxicology·Ian R Phillips, Elizabeth A Shephard
Aug 2, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tadatoshi TaninoEiichi Sakurai
Jul 19, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Ian R Phillips, Elizabeth A Shephard
Jun 17, 2006·Cancer Research·Pithi ChanvorachoteYon Rojanasakul
Mar 9, 2021·Bioanalysis·Saraswathisreeram Pranush KumarPinaki Sengupta